Duality Advisers, LP Moderna, Inc. Transaction History

Duality Advisers, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	BUY	$96.41 - $126.61 $336,374 - $441,742	3,489 Added 9.54%	40,077 $4.14 Million
Q2 2023 Jul 31, 2023	BUY	$118.5 - $160.53 $1.14 Million - $1.55 Million	9,652 Added 35.83%	36,588 $4.45 Million
Q1 2023 Jun 27, 2023	BUY	$135.66 - $197.02 $3.65 Million - $5.31 Million	26,936 New	26,936 $4.14 Million
Q1 2022 May 09, 2022	SELL	$126.46 - $235.05 $663,662 - $1.23 Million	-5,248 Closed	0 $0
Q4 2021 Feb 02, 2022	SELL	$225.82 - $368.51 $1.05 Million - $1.72 Million	-4,668 Reduced 47.08%	5,248 $1.33 Million
Q3 2021 Nov 08, 2021	BUY	$221.9 - $484.47 $252,966 - $552,295	1,140 Added 12.99%	9,916 $3.82 Million
Q2 2021 Aug 09, 2021	SELL	$129.91 - $234.98 $3.35 Million - $6.06 Million	-25,778 Reduced 74.6%	8,776 $2.06 Million
Q1 2021 May 13, 2021	SELL	$109.18 - $185.98 $5.53 Million - $9.41 Million	-50,612 Reduced 59.43%	34,554 $4.53 Million
Q4 2020 Feb 09, 2021	BUY	$65.74 - $169.86 $5.6 Million - $14.5 Million	85,166 New	85,166 $8.9 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.